Comparison of primary tumor maximal standardized uptake value (SUVmax) on preoperative [18F] fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and histological subtype in patients with non-small cell lung cancer (NSCLC)

被引:0
|
作者
Davidson, J. A.
Wong, V.
Fraser, R.
Hirsh, V.
机构
[1] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
[2] McGill Univ, Montreal, PQ, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7571
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Use of Maximum Standardized Uptake Value on Fluorodeoxyglucose Positron-emission Tomography in Predicting Lymph Node Involvement in Patients with Primary Non-small Cell Lung Cancer
    Muto, Jun
    Hida, Yasuhiro
    Kaga, Kichizo
    Ohtaka, Kazuto
    Okamoto, Shozo
    Tamaki, Nagara
    Nakada-Kubota, Reiko
    Hirano, Satoshi
    Matsui, Yoshiro
    ANTICANCER RESEARCH, 2014, 34 (02) : 805 - 810
  • [32] Heterogeneity in [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Non-Small Cell Lung Carcinoma and Its Relationship to Metabolic Parameters and Pathologic Staging
    Lopez, Ober Van Gomez
    Garcia Vicente, Ana Maria
    Honguero Martinez, Antonio Francisco
    Soriano Castrejon, Angel Maria
    Jimenez Londono, German Andres
    Manuel Udias, Jose
    Leon Atance, Pablo
    MOLECULAR IMAGING, 2014, 13
  • [33] Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients
    Wu, Yihua
    Li, Peiwei
    Zhang, Honghe
    Shi, Yu
    Wu, Han
    Zhang, Jinjie
    Qian, Yufeng
    Li, Chao
    Yang, Jun
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (02) : E37 - E47
  • [35] EFFICACY OF CONVENTIONAL COMPUTED TOMOGRAPHY AND WHOLE-BODY 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR STAGING IN NON-SMALL CELL LUNG CANCER PATIENTS
    Hsu, P-C
    Ho, K-C
    Wu, C-T
    Wu, Y-C
    Yang, C-T
    RESPIROLOGY, 2011, 16 : 167 - 167
  • [36] The relationship between maximal standardized uptake value on fluorodeoxyglucose positron emission tomography and clinical prognostic factors in non-small-cell lung cancer
    Nakamura, Y
    Watanabe, S
    Kariatumari, K
    Sakasegawa, K
    Fukumori, K
    Jinnouchi, S
    Sakata, R
    LUNG CANCER, 2005, 49 : S386 - S386
  • [37] PROGNOSTIC SIGNIFICANCE OF THE MAXIMUM STANDARDIZED UPTAKE VALUE ON POSITRON EMISSION TOMOGRAPHY ACCORDING TO HISTOLOGICAL SUBTYPES FOR NON-SMALL CELL LUNG CANCER
    Tsutani, Y.
    Miyata, Y.
    Misumi, K.
    Ikeda, T.
    Okada, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 132 - 132
  • [38] Circulating tumor cells (CTC), [18F]fluorodeoxyglucose positron emission tomography, and computed tomography (PET/CT) for treatment monitoring in patients with metastatic breast cancer (MBC)
    Tamkus, D.
    Chandana, S. R.
    Berger, K.
    Aung, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Prognostic value of fluorodeoxyglucose positron emission tomography in non-small cell lung cancer: A review
    Pillot, Giancarlo
    Siegel, Barry A.
    Govindan, Ramaswamy
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (02) : 152 - 159
  • [40] The best way for glycaemia measurement in patients undergoing 18F Fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT)
    Trevisan, M.
    Carpin, E.
    Biscotto, A.
    Zonzin, G.
    Saladini, G.
    Evangelista, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S513 - S513